EMA Authorised: Norvir (ritonavir) — AbbVie Deutschland GmbH & Co. KG

View source ↗

Summary

Norvir (ritonavir) has been authorised in the EU for HIV infections; the marketing authorization holder is AbbVie Deutschland GmbH & Co. KG.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Norvir (ritonavir)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: AbbVie Deutschland GmbH & Co. KG. Decision date: 03/11/2025